Thyroid Eye Disease - Clinical Study [US,CA] (Email,Social,Banner,Native,Push,SEO,Search,Brand Bidding) - CPL | oDigger
Join the Community
Top Networks
Top Categories
    Top Searches

      Thyroid Eye Disease - Clinical Study [US,CA] (Email,Social,Banner,Native,Push,SEO,Search,Brand Bidding) - CPL

      Promote this offer through the SmartAdv Affiliate Network

      Offer Details:


      Offer Name:

      Thyroid Eye Disease - Clinical Study [US,CA] (Email,Social,Banner,Native,Push,SEO,Search,Brand Bidding) - CPL

      Preview:

      Preview Landing Page

      Categories:

      Health

      Network:

      SmartAdv

      Status:

      Active

      Last Updated:

      Nov 24, 2024

      Date Added:

      Nov 24, 2024

      Payouts:

      $75.00 / cpa

      Countries:

      		 US / CA
      Join SmartAdv

      Affiliate Offer Description:

      You must be a member of SmartAdv to promote this offer. Click Here to join their network.
      Conversion Point: Valid Form Fill Age Range: 30-80 Gender: All GEO: US Only Traffic Allowed: Email, Social, Banner, Native, Push, SEO, Search, Brand Bidding No Incent No Co-Reg No Survey No SMS No Adult Send ad creatives and LP to AM for approval Forbidden traffic types/false Advertisements Will NOT Be Paid For Fake/false celebrity ads/endorsements are strictly prohibited Ages: 18+ Gender: Any Compensation: Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated up to $1300 for their time, in addition to travel support for transportation expenses, lodging, and reimbursement for meals. Study Details: The purpose of this clinical study is to see how effective an investigational oral medication is at helping to treat Thyroid Eye Disease (TED) associated with Graves’ Disease or Hashimoto Thyroiditis. Travel support will be provided for participants who live outside of the study site area. You may be asked to attend 1 screening visit to determine if you are eligible to enroll in the study. If enrolled, you will receive either the medication being tested in this study or a placebo to be taken twice a day for 6 months. After the treatment period, you will continue to be monitored by the study physician for a period of up to two years. Depending on your response to the study drug, you may be given the option to enroll in a follow-up study. There will be 15 study visits where you will complete various procedures and laboratory tests. Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated up to $1300 for their time, in addition to travel support for transportation expenses, lodging, and reimbursement for meals. The doctor conducting the study will be able to provide you with more information about the study requirements. Qualifications: -Must be diagnosed with either Graves' Disease or Hashimotos Thyroiditis -Experiencing symptoms only for up to a year - not longer - Cannot be diabetic
      SmartAdv

      About: SmartAdv

      SmartAdv prides itself on service and support as our state of the art infrastructure operates 24/7/365 and our account managers are at your beck and c ... Read More

      SmartAdv prides itself on service and support as our state of the art infrastructure operates 24/7/365 and our account managers are at your beck and call to provide concierge service to all of our customers. Get incredible offers to monetize websites and campaigns, in addition to generating high click-through and sales ratios, not to mention excellent payouts and terms.

      Build traffic in popular verticals and increase your profitability. We work with you to setup and maintain your solutions so you can focus on your business and increase your profits, without wasting time on technology.

      Join the industry's premier network and come grow with us!
      Read Less

      Similar offers

      var AdButler = AdButler || {}; AdButler.ads = AdButler.ads || []; var abkw = window.abkw || ''; var plc378612 = window.plc378612 || 0; var plc378614 = window.plc378614 || 0; var plc378613 = window.plc378613 || 0; var plc389895 = window.plc389895 || 0; var plc389896 = window.plc389896 || 0; var plc389897 = window.plc389897 || 0; var plc389898 = window.plc389898 || 0; var plc389899 = window.plc389899 || 0; var plc389900 = window.plc389900 || 0; var plc378615 = window.plc378615 || 0; var plc378616 = window.plc378616 || 0; var plc378623 = window.plc378623 || 0; var masterObject = { topAd: { id: 378612, counter: plc378612 }, homepageAd2: { id: 378614, counter: plc378614 }, sidebarTopAd: { id: 378613, counter: plc378613 }, sidebarAd1: { id: 389895, counter: plc389895 }, sidebarAd2: { id: 389896, counter: plc389896 }, sidebarAd3: { id: 389897, counter: plc389897 }, sidebarAd4: { id: 389898, counter: plc389898 }, sidebarAd5: { id: 389899, counter: plc389899 }, sidebarAd6: { id: 389900, counter: plc389900 }, sidebarBottomAd: { id: 378615, counter: plc378615 }, bottomAd: { id: 378616, counter: plc378616 }, offerTopAd: { id: 378623, disabled: false, counter: plc378623 } }; Object.keys(masterObject).forEach(function(key) { var entry = masterObject[key]; var element = document.getElementById(key); if (element && !entry.disabled) { document.getElementById(key).innerHTML = `
      `; AdButler.ads.push({ handler: function(opt) { AdButler.register( 161318, entry.id, [728,90], 'placement_' + entry.id + '_' + opt.place, opt ) }, opt: { place: entry.counter++, keywords: abkw, domain: 'servedbyadbutler.com', click: 'CLICK_MACRO_PLACEHOLDER' } }); } });